Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Insecticid.India
Quarter-by-quarter operating performance
| Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 357 | 302 | 640 | 696 | 358 | 272 | 657 | 627 | 358 | 359 | 691 | 638 | 385 |
| Expenses + | 333 | 331 | 594 | 614 | 332 | 264 | 585 | 538 | 327 | 330 | 607 | 548 | 358 |
| Operating Profit | 23 | -29 | 46 | 82 | 26 | 9 | 72 | 90 | 31 | 28 | 85 | 89 | 27 |
| OPM % | 7% | -9% | 7% | 12% | 7% | 3% | 11% | 14% | 9% | 8% | 12% | 14% | 7% |
| Other Income + | 0 | 0 | 4 | 0 | 1 | 5 | 3 | 2 | 0 | 3 | 4 | 3 | 1 |
| Interest | 5 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 1 | 2 | 4 | 4 | 5 |
| Depreciation | 6 | 7 | 7 | 7 | 7 | 8 | 7 | 7 | 8 | 7 | 7 | 9 | 9 |
| Profit before tax | 12 | -39 | 40 | 72 | 17 | 4 | 66 | 82 | 22 | 22 | 77 | 79 | 14 |
| Tax % | 25% | -25% | 26% | 26% | 28% | -106% | 25% | 25% | 22% | 37% | 25% | 25% | 27% |
| Net Profit + | 9 | -29 | 29 | 53 | 12 | 8 | 49 | 61 | 17 | 14 | 58 | 59 | 10 |
| EPS in Rs | 3.17 | -9.90 | 9.85 | 17.96 | 4.16 | 2.62 | 16.68 | 21.13 | 5.97 | 4.77 | 19.97 | 20.31 | 3.61 |
Financials of Insecticid.India
Annual income statement trend
| Mar 2009 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 240 | 893 | 906 | 994 | 1,073 | 1,194 | 1,363 | 1,420 | 1,504 | 1,801 | 1,966 | 2,000 | 2,073 |
| Expenses + | 211 | 782 | 814 | 882 | 925 | 1,006 | 1,207 | 1,268 | 1,333 | 1,679 | 1,804 | 1,779 | 1,843 |
| Operating Profit | 28 | 111 | 92 | 112 | 148 | 188 | 156 | 153 | 171 | 122 | 162 | 221 | 230 |
| OPM % | 12% | 12% | 10% | 11% | 14% | 16% | 11% | 11% | 11% | 7% | 8% | 11% | 11% |
| Other Income + | 1 | 0 | 0 | 7 | 3 | 1 | 3 | -2 | 3 | 1 | 10 | 8 | 11 |
| Interest | 4 | 33 | 26 | 20 | 16 | 15 | 24 | 7 | 7 | 13 | 11 | 7 | 15 |
| Depreciation | 1 | 15 | 16 | 16 | 17 | 20 | 24 | 25 | 26 | 26 | 29 | 29 | 33 |
| Profit before tax | 24 | 64 | 50 | 82 | 118 | 153 | 111 | 120 | 141 | 84 | 132 | 193 | 193 |
| Tax % | 14% | 14% | 21% | 27% | 29% | 20% | 22% | 21% | 24% | 25% | 23% | 26% | |
| Net Profit + | 21 | 55 | 40 | 60 | 84 | 123 | 87 | 94 | 107 | 63 | 102 | 142 | 142 |
| EPS in Rs | 7.34 | 19.24 | 12.77 | 19.26 | 27.19 | 39.62 | 28.04 | 30.29 | 36.29 | 21.36 | 34.49 | 48.81 | 48.66 |
| Dividend Payout % | 12% | 0% | 10% | 7% | 5% | 3% | 10% | 4% | 6% | 14% | 9% | 4% |
Financials of Insecticid.India
Capital structure and asset base
| Mar 2009 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 21 | 21 | 21 | 21 | 21 | 21 | 20 | 30 | 30 | 29 | 29 |
| Reserves | 88 | 278 | 388 | 444 | 527 | 641 | 711 | 800 | 850 | 889 | 982 | 1,056 | 1,174 |
| Borrowings + | 14 | 322 | 206 | 237 | 114 | 305 | 191 | 100 | 54 | 163 | 87 | 105 | 246 |
| Other Liabilities + | 87 | 308 | 321 | 277 | 338 | 388 | 372 | 505 | 473 | 615 | 620 | 709 | 547 |
| Total Liabilities | 201 | 920 | 936 | 978 | 1,000 | 1,356 | 1,294 | 1,426 | 1,396 | 1,696 | 1,719 | 1,898 | 1,997 |
| Fixed Assets + | 25 | 210 | 198 | 185 | 232 | 240 | 239 | 239 | 253 | 263 | 286 | 282 | 384 |
| CWIP | 1 | 38 | 51 | 58 | 17 | 19 | 39 | 59 | 91 | 123 | 142 | 161 | 81 |
| Investments | 17 | 3 | 3 | 11 | 17 | 12 | 12 | 14 | 16 | 17 | 23 | 29 | 31 |
| Other Assets + | 159 | 670 | 684 | 725 | 735 | 1,084 | 1,004 | 1,115 | 1,037 | 1,294 | 1,268 | 1,426 | 1,501 |
| Total Assets | 201 | 920 | 936 | 978 | 1,000 | 1,356 | 1,294 | 1,426 | 1,396 | 1,696 | 1,719 | 1,898 | 1,997 |
Financials of Insecticid.India
Operating, investing and financing cash movement
| Mar 2009 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 6 | -6 | 86 | 4 | 182 | -133 | 242 | 155 | 135 | -11 | 187 | 93 |
| Cash from Investing Activity + | -4 | -34 | -19 | -14 | -26 | -49 | -24 | -113 | 9 | -86 | -46 | -38 |
| Cash from Financing Activity + | -3 | 36 | -64 | 9 | -143 | 172 | -159 | -104 | -115 | 80 | -98 | -61 |
| Net Cash Flow | -1 | -4 | 4 | -0 | 13 | -11 | 59 | -61 | 30 | -17 | 42 | -5 |
| Free Cash Flow | -0 | -40 | 67 | -10 | 154 | -171 | 213 | 108 | 68 | -97 | 143 | 59 |
| CFO/OP | 32% | 1% | 108% | 19% | 140% | -54% | 175% | 120% | 103% | 16% | 124% | 61% |
Financials of Insecticid.India
Working capital efficiency and return ratios
| Mar 2009 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 50 | 68 | 84 | 78 | 80 | 75 | 86 | 65 | 70 | 60 | 55 | 70 |
| Inventory Days | 230 | 220 | 190 | 232 | 214 | 355 | 202 | 248 | 228 | 247 | 221 | 268 |
| Days Payable | 106 | 118 | 114 | 108 | 128 | 141 | 96 | 136 | 117 | 128 | 115 | 154 |
| Cash Conversion Cycle | 174 | 170 | 159 | 201 | 166 | 289 | 192 | 177 | 181 | 178 | 161 | 185 |
| Working Capital Days | 102 | 40 | 75 | 80 | 93 | 116 | 98 | 108 | 111 | 92 | 97 | 106 |
| ROCE % | 27% | 12% | 16% | 20% | 21% | 14% | 15% | 16% | 10% | 13% | 17% |
Capacity utilization indicates room for growth: 70-75% for technical and 25-30% for formulations. Key concall takeaways from GSP Crop Science Ltd's Q1 FY27…
Globally, the company’s current 4%-5% global market share offers scope to increase, meaning a 1% global share gain equates to 20%-25% volume growth for them…
Domestic sales grew 11% YoY in H1 FY '25-'26, with improved farmer connect initiatives like 'Every Day Farmers Day' enhancing demand. Key concall takeaways…
The value of these export orders in hand is approximately INR 4 to 5 crores. Key concall takeaways from Indogulf Cropsci's Q3 FY26 earnings call — and how it…